ALL |
META-ANALYSIS |
CITATIONS |
|
Benefit-Cost Summary Statistics Per Participant | ||||||
---|---|---|---|---|---|---|
Benefits to: | ||||||
Taxpayers | $9,556 | Benefits minus costs | $30,982 | |||
Participants | $21,287 | Benefit to cost ratio | $61.66 | |||
Others | $609 | Chance the program will produce | ||||
Indirect | $40 | benefits greater than the costs | 84% | |||
Total benefits | $31,492 | |||||
Net program cost | ($511) | |||||
Benefits minus cost | $30,982 | |||||
Meta-Analysis of Program Effects | ||||||||||||
Outcomes measured | Treatment age | No. of effect sizes | Treatment N | Adjusted effect sizes(ES) and standard errors(SE) used in the benefit - cost analysis | Unadjusted effect size (random effects model) | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
First time ES is estimated | Second time ES is estimated | |||||||||||
ES | SE | Age | ES | SE | Age | ES | p-value | |||||
Anxiety disorder Clinical diagnosis of an anxiety disorder (e.g., general anxiety, panic, social anxiety, obsessive compulsive disorder) or symptoms measured on a validated scale. |
31 | 4 | 74 | -0.395 | 0.175 | 31 | -0.205 | 0.214 | 33 | -0.710 | 0.004 |
Detailed Monetary Benefit Estimates Per Participant | ||||||
Affected outcome: | Resulting benefits:1 | Benefits accrue to: | ||||
---|---|---|---|---|---|---|
Taxpayers | Participants | Others2 | Indirect3 | Total |
||
Anxiety disorder | Labor market earnings associated with anxiety disorder | $8,966 | $21,120 | $0 | $0 | $30,086 |
Health care associated with anxiety disorder | $590 | $167 | $609 | $295 | $1,662 | |
Program cost | Adjustment for deadweight cost of program | $0 | $0 | $0 | ($255) | ($255) |
Totals | $9,556 | $21,287 | $609 | $40 | $31,492 | |
Detailed Annual Cost Estimates Per Participant | ||||
Annual cost | Year dollars | Summary | ||
---|---|---|---|---|
Program costs | $1,319 | 2015 | Present value of net program costs (in 2022 dollars) | ($511) |
Comparison costs | $814 | 2008 | Cost range (+ or -) | 10% |
Benefits Minus Costs |
Benefits by Perspective |
Taxpayer Benefits by Source of Value |
Benefits Minus Costs Over Time (Cumulative Discounted Dollars) |
The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in discounted dollars. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment. |
England, E.L., Herbert, J.D., Forman, E.M., Rabin, S.J., Juarascio, A., & Goldstein, S.P. (2012). Acceptance-based exposure therapy for public speaking anxiety. Journal of Contextual Behavioral Science, 1, 66-72.
Roemer, L., Orsillo, S.M., & Salters-Pedneault, K. (2008). Efficacy of an acceptance-based behavior therapy for generalized anxiety disorder: evaluation in a randomized controlled trial. Journal of Consulting and Clinical Psychology, 76 (6), 1083-9.
Craske, M.G., Niles, A.N., Burklund, L.J., Wolitzky-Taylor, K.B., Vilardaga, J.C., Arch, J.J., Saxbe, D.E., ... Lieberman, M.D. (2014). Randomized controlled trial of cognitive behavioral therapy and acceptance and commitment therapy for social phobia: outcomes and moderators. Journal of Consulting and Clinical Psychology, 82 (6), 1034-48.
Zargar, F., Asgharnejad, F.A.A., Atef-Vahid, M.K., Afshar, H., Maroofi, M., & Omranifard, V. (2012). Effect of acceptance-based behavior therapy on severity of symptoms, worry and quality of life in women with generalized anxiety disorder. Iranian Journal of Psychiatry and Behavioral Sciences, 6(2), 23-32.